Dmitrijs Rots,Arianne Bouman,Ayumi Yamada,Michael Levy,Alexander J M Dingemans,Bert B A de Vries,Martina Ruiterkamp-Versteeg,Nicole de Leeuw,Charlotte W Ockeloen,Rolph Pfundt,Elke de Boer,Joost Kummeling,Bregje van Bon,Hans van Bokhoven,Nael Nadif Kasri,Hanka Venselaar,Marielle Alders,Jennifer Kerkhof,Haley McConkey,Alma Kuechler,Bart Elffers,Rixje van Beeck Calkoen,Susanna Hofman,Audrey Smith,Maria Irene Valenzuela,Siddharth Srivastava,Zoe Frazier,Isabelle Maystadt,Carmelo Piscopo,Giuseppe Merla,Meena Balasubramanian,Gijs W E Santen,Kay Metcalfe,Soo-Mi Park,Laurent Pasquier,Siddharth Banka,Dian Donnai,Daniel Weisberg,Gertrud Strobl-Wildemann,Annemieke Wagemans,Maaike Vreeburg,Diana Baralle,Nicola Foulds,Ingrid Scurr,Nicola Brunetti-Pierri,Johanna M van Hagen,Emilia K Bijlsma,Anna H Hakonen,Carolina Courage,David Genevieve,Lucile Pinson,Francesca Forzano,Charu Deshpande,Maria L Kluskens,Lindsey Welling,Astrid S Plomp,Els K Vanhoutte,Louisa Kalsner,Janna A Hol,Audrey Putoux,Johanna Lazier,Pradeep Vasudevan,Elizabeth Ames,Jessica O'Shea,Damien Lederer,Julie Fleischer,Mary O'Connor,Melissa Pauly,Georgia Vasileiou,André Reis,Catherine Kiraly-Borri,Arjan Bouman,Chris Barnett,Marjan Nezarati,Lauren Borch,Gea Beunders,Kübra Özcan,Stéphanie Miot,Catharina M L Volker-Touw,Koen L I van Gassen,Gerarda Cappuccio,Katrien Janssens,Nofar Mor,Inna Shomer,Dan Dominissini,Matthew L Tedder,Alison M Muir,Bekim Sadikovic,Han G Brunner,Lisenka E L M Vissers,Yoichi Shinkai,Tjitske Kleefstra

Abstract:The shift to a genotype-first approach in genetic diagnostics has revolutionized our understanding of neurodevelopmental disorders, expanding both their molecular and phenotypic spectra. Kleefstra syndrome (KLEFS1) is caused by EHMT1 haploinsufficiency and exhibits broad clinical manifestations. EHMT1 encodes euchromatic histone methyltransferase-1-a pivotal component of the epigenetic machinery. We have recruited 209 individuals with a rare EHMT1 variant and performed comprehensive molecular in silico and in vitro testing alongside DNA methylation (DNAm) signature analysis for the identified variants. We (re)classified the variants as likely pathogenic/pathogenic (molecularly confirming Kleefstra syndrome) in 191 individuals. We provide an updated and broader clinical and molecular spectrum of Kleefstra syndrome, including individuals with normal intelligence and familial occurrence. Analysis of the EHMT1 variants reveals a broad range of molecular effects and their associated phenotypes, including distinct genotype-phenotype associations. Notably, we showed that disruption of the "reader" function of the ankyrin repeat domain by a protein altering variant (PAV) results in a KLEFS1-specific DNAm signature and milder phenotype, while disruption of only "writer" methyltransferase activity of the SET domain does not result in KLEFS1 DNAm signature or typical KLEFS1 phenotype. Similarly, N-terminal truncating variants result in a mild phenotype without the DNAm signature. We demonstrate how comprehensive variant analysis can provide insights into pathogenesis of the disorder and DNAm signature. In summary, this study presents a comprehensive overview of KLEFS1 and EHMT1, revealing its broader spectrum and deepening our understanding of its molecular mechanisms, thereby informing accurate variant interpretation, counseling, and clinical management.

Extending the clinical spectrum of X-linked Tonne-Kalscheuer syndrome (TOKAS): new insights from the fetal perspective

Diagnosis of tuberous sclerosis in the prenatal period: a retrospective study of 240 cases and review of the literature

A severe case of Frank-ter Haar syndrome and literature review: Further delineation of the phenotypical spectrum

Phenotypic spectrum associated with CASK loss-of-function mutations

Mutation Update for Kabuki Syndrome Genes Kmt2d and Kdm6a and Further Delineation of X-Linked Kabuki Syndrome Subtype 2

Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency

OTX2 duplications: a recurrent cause of oculo-auriculo-vertebral spectrum

Expanding the phenotypic spectrum of ARCN1-related syndrome

A new case of KIAA0753-related variant of Jeune asphyxiating thoracic dystrophy

9q33.3q34.11 microdeletion: new contiguous gene syndrome encompassing STXBP1, LMX1B and ENG genes assessed using reverse phenotyping

Expanding the genetic and clinical spectrum of Tatton-Brown-Rahman syndrome in a series of 24 French patients

TBX6-associated congenital scoliosis (TACS) as a clinically distinguishable subtype of congenital scoliosis: further evidence supporting the compound inheritance and TBX6 gene dosage model

Further delineation of the clinical spectrum of KAT6B disorders and allelic series of pathogenic variants

Further delineation of the rare GDACCF (global developmental delay, absent or hypoplastic corpus callosum, dysmorphic facies syndrome): genotype and phenotype of 22 patients with ZNF148 mutations

MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects

Bi-allelic loss-of-function variants in TMEM147 cause moderate to profound intellectual disability with facial dysmorphism and pseudo-Pelger-Huët anomaly

Multiple molecular diagnoses in the field of intellectual disability and congenital anomalies: 3.5% of all positive cases

A novel frameshift TBX4 variant in a family with ischio-coxo-podo-patellar syndrome and variable severity

Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome

Congenital Titinopathies Linked to Mutations in TTN Metatranscript-Only Exons

Genotype-phenotype correlations in a fetus with Kleefstra syndrome